Craft

Shandong Saito Biotechnology

Stock Price

¥13.5

2024-05-24

Market Capitalization

¥2.6 B

2024-05-24

Revenue

¥1.2 B

FY, 2022

Shandong Saito Biotechnology Summary

Company Summary

Overview
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. Its products include neomycin sulfate, tetraene, androstenedione, acid depletion, etc.
Type
Public
Status
Active
Founded
2010
HQ
Heze, CN | view all locations
Website
https://www.sitobiotech.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Heze, Shandong HQ

    China

    Dingtao District

Shandong Saito Biotechnology Financials

Summary Financials

Revenue (Q3, 2023)
¥282.3M
Gross profit (Q3, 2023)
¥55.4M
Net income (Q3, 2023)
¥1.0M
Cash (Q3, 2023)
¥284.6M
EBIT (Q3, 2023)
¥8.1M
Enterprise value
$3.4B

Footer menu